Similarly to KRAS mutations, GNAS mutations did not vary according to the degree of dysplasia, suggesting that mutations in these genes occur early in IPMN carcinogenesis. This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.